Sorrento Therapeutics, Inc. posts $0 million annual profit

Sorrento Therapeutics, Inc. [SRNE]  has posted annual profit of $0 million for the year ended Dec 31,2022.

The company based in California(CA)reported a fellin revenue to $0 milion for the year when compared to $52.90 million in the previous year.

A filing from the company with the Securities and Exchange Commission on Mar 16,2023 showed that its revenue is  up 100.00% year-over-year.

The company reported basic earnings per share of $0 and diluted earnings per share of $0.

Sorrento Therapeutics, Inc. operates in the Biological Products, Except Diagnostic Substances sector.